Thomas Wicks's guest appearances

Thomas Wicks

Sheppard Mullin's Nota Bene

David Garcia

Michael Hofmann

Brian Miller

Robert Friedman

Michael Roberts

John Carroll

Susan Jackson

Jonathan Meyer

Brian Weimer

Jonathan Aronie

Scott Giordano

Mike Scarborough

Paul Kim

Ben Huffman

Colleen McDonald

OwlTail

Pharmaceutical companies are part of an industry indispensable to the survival of the human species – the health industry. They’re also big business, especially considering the billions of dollars spent on research, innovation, and development of products in this space. We’re taking a look at the changing nature of clinical trials and diving into how they are conducted, reported, regulated, and any compliance issues that might arise.   Joining me for this conversation is the Chief Strategy Office at TrialScope, Thomas Wicks. Thomas has over 18 years of experience with performance and content management solutions, specializing in applications for life sciences such as clinical trial disclosure, structured product labeling, and submissions management and has been on the PharmaCM team since 2007. What We Discussed in this Episode:  How are clinical trial results harmonized and regulated uniformly given various industries in every country run trials? What do clinical trials and research entail? What is a Phase I trial and what is being measured during this phase? What do researches look for in Phase II and Phase III studies? Once a product makes it through the first three phases of research and study, what happens next? In what form are clinical trial results presented? Why was there a shift towards greater transparency in disclosures of pharmaceutical studies? How are European countries helping academic researchers? What type of information is required to be disclosed? Does it vary by type of company? With the coronavirus still spreading, how many clinical trials have been or are being conducted? What are the trials testing?  Contact Information: Thomas's LinkedIn thomas@trialscope.com Additional Resources: www.CoronaClinicalTrials.com Press Release www.clinicaltrials.gov Thank you for listening! Don’t forget to SUBSCRIBE to the show to receive every new episode delivered straight to your podcast player every Wednesday.  If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show in  Apple Podcasts,  Stitcher Radio,  Google Play, or Spotify.  It helps other listeners find this show.  Be sure to connect with us and reach out with any questions/concerns:  LinkedIn Facebook Twitter   Sheppard Mullin website  This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.

Pharmaceutical companies are part of an industry indispensable to the survival of the human species – the health industry. They’re also big business, especially considering the billions of dollars spent on research, innovation, and development of products in this space. We’re taking a look at the changing nature of clinical trials and diving into how they are conducted, reported, regulated, and any compliance issues that might arise.   Joining me for this conversation is the Chief Strategy Office at TrialScope, Thomas Wicks. Thomas has over 18 years of experience with performance and content management solutions, specializing in applications for life sciences such as clinical trial disclosure, structured product labeling, and submissions management and has been on the PharmaCM team since 2007. What We Discussed in this Episode: <ul> <li>How are clinical trial results harmonized and regulated uniformly given various industries in every country run trials?</li> <li>What do clinical trials and research entail?</li> <li>What is a Phase I trial and what is being measured during this phase?</li> <li>What do researches look for in Phase II and Phase III studies?</li> <li>Once a product makes it through the first three phases of research and study, what happens next?</li> <li>In what form are clinical trial results presented?</li> <li>Why was there a shift towards greater transparency in disclosures of pharmaceutical studies?</li> <li>How are European countries helping academic researchers?</li> <li>What type of information is required to be disclosed? Does it vary by type of company?</li> <li>With the coronavirus still spreading, how many clinical trials have been or are being conducted? What are the trials testing?</li> </ul> Contact Information: Thomas's <a href="https://www.linkedin.com/in/thomaswicks" rel="noopener nofollow" target="_blank">LinkedIn</a> <a href="mailto:thomas@trialscope.com">thomas@trialscope.com</a> Additional Resources: <a href="http://www.coronaclinicaltrials.com/" rel="noopener nofollow" target="_blank">www.CoronaClinicalTrials.com</a> <a href="https://www.clinicalleader.com/doc/new-website-a-free-resource-for-researchers-patients-on-covid-trials-0001" rel="noopener nofollow" target="_blank">Press Release</a> <a href="http://www.clinicaltrials.gov" rel="nofollow" target="_blank">www.clinicaltrials.gov</a> Thank you for listening! Don’t forget to SUBSCRIBE to the show to receive every new episode delivered straight to your podcast player every Wednesday.  If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show in <a href="https://itunes.apple.com/us/podcast/sheppard-mullins-nota-bene/id1434557969" rel="nofollow" target="_blank"> Apple Podcasts</a>, <a href="https://www.stitcher.com/podcast/sheppard-mullins-nota-bene?refid=stpr" rel="nofollow" target="_blank"> Stitcher Radio</a>, <a href="https://play.google.com/music/listen#/ps/Ik3spc76qzkbnshaddtccqi4wum" rel="nofollow" target="_blank"> Google Play</a>, or Spotify.  It helps other listeners find this show.  Be sure to connect with us and reach out with any questions/concerns: <a href="https://www.linkedin.com/company/sheppard-mullin-richter-&amp;-hampton-llp" rel="nofollow" target="_blank">LinkedIn</a> <a href="https://www.facebook.com/SheppardMullin" rel="nofollow" target="_blank">Facebook</a> <a href="https://twitter.com/SheppardMullin" rel="nofollow" target="_blank">Twitter </a> <a href="https://www.sheppardmullin.com/publications-podcasts.html" rel="nofollow" target="_blank"> Sheppard Mullin website</a>  This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.

Clinical Trial Disclosures on the World Map with TrialScope Chief Strategy Officer Thomas Wicks [NB 075]